Glycogen Storage Disease Type 1A (part of Ashkenazi FlexPanel)

PrintPrint

This test is part of the Ashkenazi FlexPanel.

Disease Name 
Glycogen Storage Disease Type 1A
Disease Information 

Glycogen Storage Disease Type Ia (GSDIa) is characterized by accumulation of glycogen and fat in the liver and kidneys. Long-term complications of untreated GSDIa include growth retardation and resulting short stature, delayed puberty, gout, renal disease, pulmonary hypertension and changes in brain function. Normal growth and puberty may be expected in treated children, and many affected individuals live into adulthood. It is an autosomal recessive disorder caused by mutations in the G6PC gene. It occurs more frequently in the Ashkenazi Jewish population, where the carrier rate is 1 in 71. Ashkenazi Jewish individuals with a negative family history who test negative for the R83C and Q347X mutations in G6PC have a revised carrier risk of 1 in 7,000.

Test Description 

 

Analysis of the R83C and Q347X in G6PC by pyrosequencing. This test can be ordered as part of the Ashkenazi Jewish FlexPanel.  

 

Mutation Detection Rate 

The mutation detection rate in the Ashkenazi Jewish population is 99%.

Genes